COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)

NCT00132899 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Methotrexate
DRUG: Placebo

Sponsor

University of Western Ontario, Canada

Collaborators

[object Object]